Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

NYSE:CMG

Chipotle Mexican Grill (CMG)

38.03
+0.81 (2.18%)
as of Aug 28, 2026, 8:00:00 pm Market Open.
91 watching
0
Investor Insights
star iconAug 30, 2026, 12:00 am

This summary was created by AI, based on 7 opinions in the last 12 months.

Chipotle Mexican Grill (CMG-N) has experienced volatility in its stock performance, down approximately 29% following a tax loss, suggesting an early entry point may have been premature. Recent financial results indicate a modest recovery, attributed to a slight earnings beat and better-than-expected sales growth after facing challenges under new leadership for the past two years. Analysts have expressed cautious optimism, anticipating about a 15% upside, yet advise patience given current market conditions exacerbated by rising beef prices and a lettuce recall issue. The general sentiment suggests that while the stock has seen significant declines (down 25-30%), the turnaround strategy is being believed by investors, although execution remains critical for future performance. The stock is considered more of a value play currently, despite the absence of dividends, and reflects long-term brand loyalty in a challenging environment.

consensus icon
Consensus
Cautious
valuation icon
Valuation
Overvalued
review icon
Similar
SBUX
COMMENT

CMG vs. MCD: Why don't the stocks move in tandem if they're in the same business? CMG is going all-in with tech. CMG is more technologically savvy than MCD, though MCD is a good business. MCD is a dinosaur in comparison. MCD, though, is a great company.

BUY
Will survive the winter lockdown and either presidential candidate. They've invested seriously in take-out food to offset the losses of dine-in. They have adapted well.
DON'T BUY
Loyal customers are still lining up, despite the pandemic. Valuation is 74x earnings for a 23% growth rate, so a PEG ratio of 3, and that's a little expensive for him. Strong revenues, but expensive valuation.
COMMENT

Time to add? They are only in 26 states so far, so there is a long playing field for SHAK-N. It trades at a high multiple, so if they disappoint it can become very painful quickly. Be cautious. He prefers to own the established names like SBUX-Q or CMG-N.

PAST TOP PICK

(A Top Pick July 19/17 - Down 12%) She had it with the expectation that it’s taken over. 4% yield in the meantime.

DON'T BUY

Not keen on it. What made them terrific before may not continue: quality food and good value, then people got sick. He's unconvinced they can regain that public goodwill.

BUY ON WEAKNESS

He continues to watch this stock, he thinks it is worth $180 and the recent close makes it too expensive. However, he has been saying this since it traded $500. He will wait for his target.

PAST TOP PICK

*Short* (A Top Pick Nov 3/17, Up 11%) It was a combination of an e-coli scare, overvaluation and a growth stock becoming a value play. It is still not a cheap enough stock for him to find any level of support.

COMMENT

He is more positive on this on the margin. Technically it still has a little bit of work to do. The earnings trends are more on the positive inflection, as opposed to a “show me” story. It has pulled back more recently. Looking at a slightly longer-term chart, you can see the cup coming up and breaking out on a medium-term basis. This is shaping up nicely, and he is positive on the space itself.

BUY ON WEAKNESS

His model price is $203. He was praying the stock would come back to his model price. Bill Ackman has now taken a position in the company and is doing some activist stuff. He would love to see this come back to $394.

COMMENT

They had some earnings hits in the last couple of quarters. It is not cheap, 30-40 times earnings, but the growth rate is really good. It still has some more to prove in his opinion. There are so many people who bought this in 2014/15 and are under water and want to sell this to get their money back and it creates some resistance levels.

TOP PICK

Short. They ran into E. Coli problems just over a year ago, a month after the stock peaked. The stock is down materially over the last year and is still expensive, priced for growth. It is 120 times earnings. They keep missing on earnings.

TOP PICK

*Short*(Pairs Trade with a Long on A&W Revenue Royalties (AW.UN-T). This is having all kinds of problems. Their same-store sales are still in decline. The declines are improving every quarter, but not in a major way.

COMMENT

This had 2 outbreaks, one on top of the other. The issue is, can they gain back consumers’ trust. You go there because it’s cool and very healthy, as compared to others. They have a long way to climb back. If they can do that, this would be a screaming buy.

PAST TOP PICK

(A Top Pick April 15/15. Down 38.43%.) Had owned this for quite a few years. Got stopped out during the E. coli outbreak, but still lost money on the trade.

Showing 76 to 90 of 104 entries